EKF Diagnostics acquires 709,193 of its own shares at 28p
PositiveFinancial Markets

EKF Diagnostics has successfully acquired 709,193 of its own shares at a price of 28p each. This strategic move reflects the company's confidence in its future prospects and aims to enhance shareholder value. Such buybacks can signal to the market that the company believes its shares are undervalued, potentially boosting investor confidence and interest.
— Curated by the World Pulse Now AI Editorial System